[ET Net News Agency, 27 August 2026] INNOGEN-B (02591) fell 4.2% to HK$3.85.
It hits an intra-day low of HK$3.85, hitting a historical low, and an intra-day high of HK$4.05. The total shares traded was 1.28 million, with a value of HK$5.08m. The active buy/sell ratio is 28:72, with net selling turnover of HK$2.16m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$747,131, with volume weighted average price of HK$3.973. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$182,176, with volume weighted average price of HK$3.876. The stock has fallen a combined 46.5% over the past 12 consecutive trading days.
Basic Information| Nominal | 3.850 | % Chg | -4.23% |
| High | 4.050 | Low | 3.850 |
| Shares Tr | 1.28m | Turnover | 5.08m |
| 10-D SMA | 4.438 | %H.V | 119.470 |
| 20-D SMA | 5.833 | VWAP | 3.967 |
| 50-D SMA | 7.028 | RSI14 | 19.405 |
Status: Hitting a historical low, active buy/sell ratio is 28:72, with net selling turnover of HK$2.16m, falling a combined 46.5% over the past 12 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 3.85 | -4.23 |
| GENSCRIPT BIO (01548) | 33.76 | -4.47 |
| INNOVENT BIO (01801) | 108.60 | -1.09 |
| EVEREST MED (01952) | 36.34 | -4.12 |
| WUXI XDC (02268) | 74.60 | -3.43 |
| WUXI BIO (02269) | 49.64 | -2.19 |
| BEONE MEDICINES (06160) | 224.80 | -1.49 |
| CANSINOBIO (06185) | 32.78 | -8.13 |
| AKESO (09926) | 97.75 | +3.77 |
| REMEGEN (09995) | 81.20 | +1.00 |
(ed)
Nominal 
